Stock Price Quote

SHARON BIO-MEDICINE LTD.

NSE : SHARONBIOBSE : 532908ISIN CODE : INE028B01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.210 (0 %)
PREV CLOSE ( ) 3.21
OPEN PRICE ( ) 3.26
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 32550
TODAY'S LOW / HIGH ( )3.10 3.30
52 WK LOW / HIGH ( )3.1 4.65
NSE3.300 (0 %)
PREV CLOSE( ) 3.30
OPEN PRICE ( ) 3.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8834
TODAY'S LOW / HIGH( ) 3.30 3.30
52 WK LOW / HIGH ( )2.95 4.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-06 1989
Management Info
- Chairman Savita Satish Gowda - Managing Director
Registered Office

Address W 34 & 34 / 1,M I D C,Taloja,
Raigad,
Maharashtra-410208

Phone 022- 65132070 /65132071 /6794 4000

Email investor_complaints@sharonbio.com

Website www.sharonbio.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX, Pune

NEWS

17Jan Sharon Bio Medicine informs about conf
Pursuantto Regulation 74 (5) of Securities and Exchange Board of India (..
21Nov Sharon Bio-Medicine informs about outc
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
30Sep Sharon Bio-Medicine informs about clos
Pursuant to the provisions of the SEBI (Prohibition of Insider Trading)..
19Jul Sharon Bio-Medicine informs about comp
Sharon Bio-Medicine has informed that it enclosed the Confirmation Certi..
07Feb Sharon Bio-Medicine informs about unau
Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requir..

Financials

in Millions
QTR Mar 23 ANNUAL 23
Net Profit18.06190.06
Gross Profit 18.06 190.06
Operating Profit 43.08298.1
Net Sales 442.371949.79

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  28639.35 (0.55%)
M.Cap ( in Cr)60856.62
Bharat Parenterals (BSE)
peergroup  1147.65 (10.28%)
M.Cap ( in Cr)667.89
Astrazeneca Pharma I (BSE)
peergroup  5567.65 (1.95%)
M.Cap ( in Cr)13919.13
Neuland Laboratories (BSE)
peergroup  7063.75 (1.37%)
M.Cap ( in Cr)9062.71
Mankind Pharma (BSE)
peergroup  2097.55 (1.58%)
M.Cap ( in Cr)84025.43

Shareholding Pattern

NON-INSTITUTION 99.98%
FI/BANKS/INSURANCE 0.02%
PROMOTERS 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Sharon Bio-Medicine Ltd.

Sharon Bio-Medicine Ltd. was incorporated in the year 1989. Its today's share price is 3.21. Its current market capitalisation stands at Rs 1.85 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2534.55 Cr and Total Income of Rs.2554.04 Cr. The company's management includes Rakhi Makhloga, Harish Palecanda, Nivedita Patil, Lalit Misra, Savita Satish Gowda.

It is listed on the BSE with a BSE Code of 532908 , NSE with an NSE Symbol of SHARONBIO and ISIN of INE028B01029. It's Registered office is at W 34 & 34 / 1,M I D C,TalojaRaigad-410208, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Shyam C Agrawal & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.